8/3/17 20:58 | 8/1/17 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | WA | D | | M.d | 0 | 0.00 | 0 | 5 | 22 | 26 | M | | | | | | | | | | | | | | |
6/14/17 16:39 | 6/12/17 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 14 | 7 | 234 | M | | | | | | | | | | | | | | |
1/12/17 11:31 | 1/10/17 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 1 | 31 | 16 | 224 | M | -74 | -28 | -40 | 37 | 16 | 28 | 18 | -16 | 8 | -5 | -2 | -27 | | |
6/15/16 17:50 | 6/13/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 1 | 14 | 8 | 203 | M | -68 | -61 | -8 | 30 | 6 | 11 | -10 | 7 | -3 | -3 | -9 | -49 | -50 | |
6/15/16 17:50 | 6/13/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -5 | 1.03 | 1 | -5 | -2 | 203 | M | -68 | -61 | -8 | 30 | 6 | 11 | -10 | 7 | -3 | -3 | -9 | -49 | -50 | |
3/16/16 18:26 | 3/14/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 25 | 15 | 194 | D | -93 | -64 | -67 | -29 | 34 | 32 | 11 | 6 | -4 | -6 | 1 | 31 | -36 | -38 |
3/16/16 18:26 | 3/15/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -10 | 0.8300 | 0 | -12 | -6 | 194 | D | -93 | -64 | -67 | -29 | 34 | 32 | 11 | 6 | -4 | -6 | 1 | 31 | -36 | -38 |
6/16/15 15:06 | 6/12/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 2 | 9 | 9 | 112 | D | -72 | -18 | 18 | 19 | 38 | 28 | 10 | -1 | -3 | 1 | -10 | -9 | -58 | -61 |
6/16/15 15:06 | 6/12/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -12 | 2.69 | 2 | -5 | -4 | 112 | D | -72 | -18 | 18 | 19 | 38 | 28 | 10 | -1 | -3 | 1 | -10 | -9 | -58 | -61 |
5/21/15 18:28 | 5/19/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 16 | 17 | 107 | D | -82 | -50 | -14 | -16 | -18 | -6 | 6 | -3 | -2 | 14 | 45 | 48 | 24 | -52 |
5/21/15 18:28 | 5/20/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -14 | 1.88 | 0 | -8 | -7 | 107 | D | -82 | -50 | -14 | -16 | -18 | -6 | 6 | -3 | -2 | 14 | 45 | 48 | 24 | -52 |
1/30/15 18:46 | 1/27/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 1 | 20 | 25 | 99 | D | -85 | -80 | -34 | -8 | -10 | -12 | -11 | -4 | 2 | -1 | 20 | 0 | 61 | -67 |
9/19/14 15:31 | 9/17/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 1 | 7 | 9 | 88 | D | -79 | -68 | -76 | -15 | -5 | -9 | -5 | -2 | -7 | -8 | -27 | -26 | -23 | -3 |
8/14/14 18:01 | 8/12/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 38 | 80 | 84 | D | -77 | -65 | -72 | -17 | -9 | 3 | 12 | 5 | 0 | -3 | -5 | -35 | -36 | -4 |
8/14/14 18:01 | 8/13/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -58 | 3.17 | 0 | -18 | -18 | 84 | D | -77 | -65 | -72 | -17 | -9 | 3 | 12 | 5 | 0 | -3 | -5 | -35 | -36 | -4 |
3/18/14 19:22 | 3/14/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 4 | 9 | 8 | 122 | D | -21 | 1 | 35 | 53 | 16 | 9 | 0 | -5 | -1 | -1 | -23 | -76 | -80 | -86 |
3/18/14 19:22 | 3/17/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -57 | 12.25 | 4 | -5 | -4 | 122 | D | -21 | 1 | 35 | 53 | 16 | 9 | 0 | -5 | -1 | -1 | -23 | -76 | -80 | -86 |
10/7/13 15:21 | 8/19/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.a | -27 | 8.68 | 1 | -3 | -5 | 60 | D | -2 | -38 | -14 | -8 | -3 | -3 | -1 | -2 | -1 | -1 | -22 | 3 | 10 | -73 |
10/7/13 15:19 | 3/12/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.a | -25 | 11.90 | 1 | -2 | -4 | 57 | D | -2 | -38 | -14 | -8 | -3 | -3 | -1 | -2 | -1 | -1 | -22 | 3 | 10 | -73 |
8/15/13 18:06 | 8/13/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 1 | 7 | 6 | 118 | D | -21 | -36 | -23 | -9 | -1 | -8 | -5 | -1 | 0 | -1 | 3 | -19 | 31 | -61 |
3/14/13 17:04 | 3/12/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 0 | 0.00 | 1 | 5 | 4 | 114 | D | -21 | -23 | -12 | -6 | -9 | 0 | -3 | -1 | 0 | -4 | -14 | -19 | -25 | 1 |
8/7/12 13:57 | 8/7/12 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 29 | 4.11 | 1 | 7 | 7 | 112 | D | -3 | 25 | -4 | 12 | 7 | -1 | 2 | 3 | -1 | -2 | -5 | -15 | -16 | -34 |
8/1/12 18:03 | 7/30/12 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 140 | 4.11 | 0 | 34 | 48 | 105 | D | -5 | -1 | 0 | 7 | 4 | -2 | -3 | -1 | -2 | 2 | 2 | -11 | -8 | -29 |
8/8/11 14:30 | 8/5/11 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 21 | 4.11 | 1 | 5 | 8 | 70 | M | -60 | -23 | -29 | -26 | -34 | -27 | -20 | -15 | -11 | -1 | -8 | 1 | 31 | 25 |
1/6/11 19:05 | 1/4/11 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.dm | 73 | 3.89 | 1 | 19 | 40 | 65 | M | 286 | -21 | 31 | 19 | 5 | 7 | 7 | 2 | -1 | 0 | -7 | -10 | 0 | -34 |
1/6/11 19:05 | 1/4/11 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -165 | 16.52 | 1 | -10 | -13 | 65 | M | 286 | -21 | 31 | 19 | 5 | 7 | 7 | 2 | -1 | 0 | -7 | -10 | 0 | -34 |
12/10/10 12:11 | 12/8/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 99 | 9.92 | 1 | 10 | 21 | 57 | I | 163 | -50 | 12 | 27 | -1 | -3 | 0 | -1 | 0 | 0 | 6 | -6 | 16 | -33 |
12/3/10 16:52 | 12/1/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.dm | 39 | 3.89 | 1 | 10 | 21 | 57 | M | 611 | -52 | 12 | 23 | -8 | 0 | -4 | -1 | 0 | 0 | 5 | -3 | 13 | -28 |
12/3/10 16:52 | 12/1/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -80 | 16.02 | 1 | -5 | -8 | 57 | M | 611 | -52 | 12 | 23 | -8 | 0 | -4 | -1 | 0 | 0 | 5 | -3 | 13 | -28 |
11/17/10 16:19 | 11/15/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.dm | 39 | 3.89 | 2 | 10 | 24 | 52 | M | 563 | -49 | -7 | 15 | 11 | -5 | 0 | -1 | 3 | 2 | 0 | -1 | -3 | -23 |
11/17/10 16:19 | 11/15/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -80 | 15.99 | 2 | -5 | -9 | 52 | M | 563 | -49 | -7 | 15 | 11 | -5 | 0 | -1 | 3 | 2 | 0 | -1 | -3 | -23 |
11/2/10 18:58 | 11/1/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 39 | 3.89 | 3 | 10 | 27 | 47 | D | 513 | -45 | -27 | 6 | 30 | -14 | -9 | -5 | -1 | -3 | -2 | -3 | -5 | -30 |
11/2/10 18:58 | 11/1/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -77 | 15.45 | 3 | -5 | -10 | 47 | D | 513 | -45 | -27 | 6 | 30 | -14 | -9 | -5 | -1 | -3 | -2 | -3 | -5 | -30 |
8/27/10 13:49 | 8/25/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | O | P,CEO | M.d | 7 | 3.89 | 0 | 2 | 4 | 42 | D | 89 | -62 | -25 | -18 | 1 | -16 | -10 | -5 | 4 | 4 | 5 | 31 | 26 | -13 |
1/29/10 11:04 | 1/28/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 28 | 3.89 | 4 | 7 | 21 | 40 | I | 101 | 167 | -51 | -55 | -53 | -34 | -21 | -8 | 0 | 5 | 20 | 52 | 0 | 13 |
7/10/09 16:28 | 7/10/09 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 3 | 3.89 | 5 | 1 | 3 | 33 | B | | | | | | | | | 0 | 6 | 46 | 79 | 5 | -36 |
12/29/08 10:20 | 12/23/08 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | M.d | 97 | 3.89 | 1 | 25 | 339 | 32 | M | -96 | -45 | -14 | 7 | 70 | -43 | -26 | 3 | -23 | 3 | 27 | 1 | 445 | 438 |
9/29/08 16:32 | 9/26/08 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | P | 20 | 3.99 | 0 | 5 | 383 | 6 | D | -95 | -65 | -40 | -20 | -14 | -34 | -12 | -5 | 0 | 3 | -14 | 16 | 17 | 858 |